Jun 16, 2020
FDA Approves First Treatment for Adult Onset Still's Disease, a Severe and Rare Disease
May 13, 2020
Hydroxychloroquine Market Size Worth Around US$ 6 Bn by 2027
Apr 20, 2020
COVID-19 Update - Hydroxychloroquine Market was Estimated to be US$ 41.3 Mn in 2018 and is Growing at a CAGR of 10.4% Over the Forecast Period, Owing to Increasing Demand for Medications to Treat Autoimmune Diseases, Says Absolute Markets Insights
Mar 20, 2020
New Research Among People Living With Rheumatoid Arthritis Reveals Key Determinants Of Patient Satisfaction With Doctors
Mar 12, 2020
Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
Jan 17, 2020
AMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco
Nov 08, 2019
Global $18 Billion Autoimmune Disease Diagnostic Markets to 2026
Sep 17, 2019
Rheumatologist Dr. Jenny Gartshteyn Joins CORE Medical & Wellness in Lyndhurst, NJ
Aug 05, 2019
The global rheumatoid arthritis diagnostic devices market at a CAGR of almost 6% during the forecast period
Jul 19, 2019
International Lupus Community Reaches First-Ever Agreement on Barriers to Research, Drug Development, Care and Access
Jun 13, 2019
VALUE Study Results Show Custom Mobile App Lets Patients Accurately Report Response to Treatment
May 29, 2019
New Study Partly Funded by the Lupus Research Alliance Reveals Novel Lupus Drug Targets
May 29, 2019
Mallinckrodt Announces Positive Open-Label Results from Phase 4 Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Rheumatoid Arthritis (RA) to be Presented at the European Congress of Rheumatology 2019 (EULAR)
May 20, 2019
Lupus Treatments Can Be Tailored to Patient's Individual Cells, Study Shows
May 14, 2019
Antinuclear Antibody Test Market Size Worth $2.36 Billion by 2025: Grand View Research, Inc.
May 02, 2019
Mallinckrodt to Present Open-Label Results from Phase 4 Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Patients with Rheumatoid Arthritis at Annual European Congress of Rheumatology (EULAR 2019)
Apr 01, 2019
Rheumatoid Arthritis Drugs Market to Record a CAGR of Approx 10.5% During 2019-2024
Mar 06, 2019
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus
Feb 05, 2019
Mallinckrodt Provides Update on Phase 4 Data H.P. Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Patients with Rheumatoid Arthritis (RA)
Jan 29, 2019
imaware(TM) Partners with Rheumatoid Patient Foundation to Promote Awareness and Early Diagnosis of Rheumatoid Arthritis